- Lobbying
- Lobbying by Agios Pharmaceuticals Inc.
Lobbying Relationship
Bills mentioned
H.R.5376: Inflation Reduction Act of 2022
Sponsor: John Yarmuth (D-Ky.)
Lobbyists
Lobbyists named here were listed on a filing related to this lobbying engagement. They may not be working on it now. Occasionally, a single lobbyist whose name is spelled two different ways on filings may be represented twice here.
Lobbyist | Covered positions? |
---|---|
Jonathon Jones | Chief of Staff, Senator Carper; Legislative Director, Senator Carper. |
Andrew McKechnie | Health Policy Advisor, Sen. Finance Committee; Legislative Assistant, Senator Norm Coleman; Legislative Assistant, Rep. Jim Ramstad; Bipartisan Medical Technology Caucus. |
Disclosures Filed
Once a lobbying engagement begins, the lobbyist or firm is required to file updates four times a year. Those updates sometimes change which lobbyists are involved or add new issues being discussed. When lobbyists stop working for a client, the firm is also supposed to file a report disclosing the end of the relationship.
Termination
Q3 Report
Q2 Report
Q1 Report
Q4 Report
Q3 Report
Q2 Report
Q1 Report
Q4 Report
Q3 Report
Lobbying Issues
Agencies Lobbied
Type of Issue
Q2 Report
Q1 Report
Registration
Issue(s) they said they’d lobby about: Issues related to the pharmaceutical industry..
Source: Clerk of the U.S. House of Representatives and Secretary of the Senate